Recently, Ulijanovs et al. described that the fraction of parenchymal cells positive for vimentin varies in healthy tissue, hyperplasia, adenoma, and carcinoma, with percentages of 9%, 11.7%, 19.3%, and 36.8%, respectively. This evidence concerns the gene VIM and adenoma.